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Introduction: Vitamin D deficiency is common in critically ill patients, and was reported to be associated with
adverse outcomes. However, the effect of vitamin D deficiency on mortality in critically ill patients remains unclear.
Methods: We searched PubMed and EMBASE from the inception to July 2014 for cohort studies to assess the
effect of vitamin D deficiency on the incidence of mortality in critically ill patients. Mortality-specific odds ratio (OR)
with 95% confidence interval (CI) were pooled with a random- or fixed-effect models when appropriate.
Results: Seven cohort studies with a total of 4,204 participants including 1,679 cases of vitamin D deficiency were
included in this meta-analysis. Vitamin D deficiency was significantly associated with an increased hospital mortality
(OR 1.76; 95% CI, 1.38 to 2.24; P <0.001), with very low heterogeneity (I2 = 2.3%; P = 0.402). The finding of increased
hospital mortality in critically ill adult patients was consistently found in every stratum of our subgroup analyses.
Conclusions: This meta-analysis suggests that vitamin D deficiency is associated with increased incidence of
hospital mortality in critically ill adult patients.Introduction
Vitamin D is a group of fat-soluble vitamins that play a
significant role in the regulation of bone metabolism [1],
it also plays a major role in extra-skeletal metabolic pro-
cesses, such as glucose metabolism, and in many aspects
of cellular functions [2,3]. Vitamin D deficiency is asso-
ciated with various disorders such as diabetes, infections,
myocardial infarction, autoimmune disease, chronic ob-
structive pulmonary disease, tuberculosis, and excess
mortality in the general population [4]. The incidence of
vitamin D deficiency has been reported to range from
26% to 82% in critically ill patients [5,6], and mounting
evidence indicates that vitamin D deficiency is associated
with adverse outcomes such as increased infection rates,* Correspondence: suntongwen@163.com; 1017361289@qq.com;
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unless otherwise stated.prolonged length of ICU stay [7], higher in-hospital
mortality [8], and increased health care costs [9]. How-
ever, Ralph et al. [10] did not observe an association
between low levels of vitamin D and increased risk of
mortality in critically ill patients, but they did find that
patients with above physiological vitamin D levels had
higher mortality and illness severity scores.
At present, the effect of vitamin D deficiency on out-
comes such as mortality and morbidity in critically ill
patients is not clear. We conducted a meta-analysis of
seven cohort studies to investigate the effect of vitamin
D deficiency on clinical outcomes such as hospital mor-




The search was carried out in keeping with the statement
of meta-analysis of observational studies in epidemiology
(MOOSE) [11]. Without language restrictions, the literature
from the inception to July 2014 was searched in PubMed
and EMBASE. The following search terms were used:
‘Vitamin Dʼ, ‘cholecalciferolʼ, ‘hydroxycholecalciferolsʼ,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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terolʼ, ‘critical illʼ and ‘critically illʼ. Furthermore, we
reviewed the reference lists in the retrieved articles and
recent reviews to identify other potential relevant studies.
Study selection
A published study was included if it: 1) was a cohort
design; 2) explored the effect of vitamin D deficiency on
mortality in the critically ill adult patients; 3) reported
the adjusted effect size and its 95% CI. In the case of
duplicate publication, we only included studies that were
the most informative and complete.
Data extraction and quality assessment
The following information was abstracted from all the
included studies by using a standardized data collection
form: study name (together with the first author’s name
and publication year), study design, country, popula-
tion characteristics, number of patients, number of
vitamin D deficiency cases, gender composition in pa-
tients, mean age of the patients, severity of illness by sim-
plified acute physiology score (SAPS) or acute physiology
and chronic health evaluation (APACHE) score, definition
of vitamin D deficiency, major clinical outcomes, and
quantity score. We also checked the supplementary files,
and contacted the authors for more detailed information
where necessary.
We assessed the authenticity and quality of the in-
cluded studies by Newcastle-Ottawa scales (NOS) [12],
in which a study was judged on three broad perspectives
consisting of eight items. We assigned risk-of-bias cat-
egories in accordance with the number of adequate
items of NOS that were judged in each study: assessing the
following categories: low risk of bias (six to eigt adequate
items), medium risk of bias (four to five adequate items),
high risk of bias (fewer than four adequate items), very
high risk of bias (no description of methods). Two investi-
gators (YP Zhang and YD Wan) carried out the literature
search, study selection, data extraction and quality assess-
ment independently. Any discrepancies were resolved by
consensus.
Statistical analysis
To compute a summary odds ratio (OR), we used the
adjusted OR and its 95% CI in all analyses. The hazard
ratio (HR) was considered as the OR directly. The hetero-
geneity test was conducted using the Cochran Q-statistic
at the P <0.10 level of significance. We also quantified the
I2 statistic, which describes the inconsistency due to the
heterogeneity across studies [13-15]. An I2 value >50%
indicates significant heterogeneity. The appropriate pool-
ing method was decided according to the value of the
I2 statistic: fixed-effects models for I2 < 50% and random-
effects models for I2 ≥ 50% [13-15]. Prespecified subgroupanalyses were performed according to minimum serum
25-hydroxyvitamin D (25(OH)D) level as the threshold to
define vitamin D deficiency (20 ng/ml, 15 ng/ml, 12 ng/ml,
10 ng/ml) to examine the influence of this clinical factor
on the overall risk estimation. We also conducted a sensi-
tivity analysis by changing the pooling model (fixed-effects
model or random-effects model) and using the one-study-
out method and applying various exclusion criteria to test
the robustness of the pooled estimate. Potential publication
bias was assessed by the Egger linear regression test
[16]. P <0.05 was considered to be representative of a
significant statistical publication bias, except where other-
wise specified. All statistical analyses were performed by
using STATA, version 11.0 (Stata Corp).
Results
Study selection and study characteristics
Our initial search yielded 98 potentially relevant publi-
cations, 3 of which were excluded for duplicate publi-
cations. We excluded 62 studies based on title and
abstract review. After reviewing the full text of the
remaining 33 studies, we identified 7 cohort studies in
this present meta-analysis [8,17-22]. The reasons for
excluding studies in the final review included: reviews
and editorial articles, small sample size (n <100), not
relevant to our analysis, and studies not reporting ad-
justed ORs of risk estimates and the 95% CI (see the detail
in Figure 1).
The main characteristics of the seven studies included
in this meta-analysis are shown in Table 1. In total,
4,204 participants including 1,679 cases of vitamin D de-
ficiency were enrolled in this meta-analysis. The study-
design types were as follows: single-center studies (n = 4
[8,18,19,22]), multicenter studies (n = 3 [17,20,21]), retro-
spective studies (n = 3 [8,17,22]), and prospective studies
(n = 4 [18-21]). Six studies presented outcome of hospital
mortality [8,17,18,20-22], and only two studies presented
outcome of ICU mortality [19,22]. As for length of ICU
stay, one study provided data expressed as mean ± SD [8],
two studies did not report it [17,20], and the remaining
four described the data as median [18,19,21,22]. Every
single study was matched or adjusted for a wide range of
potential confounders. There is no consistent definition of
vitamin D deficiency between included studies. The aver-
age NOS score of the included studies was 6.6 (range from
6 to 7). An additional table file shows this in more detail
(Additional file 1).
Overall results
Combined by the fixed-effects model, the multivariable-
adjusted OR for hospital mortality and ICU mortality for
each study is shown in Figures 2 and 3, respectively. Re-
sults from six studies showed that vitamin D deficiency
is associated with an increased risk of hospital mortality
Figure 1 Flow chart of article selection. OR, odds ratio.
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heterogeneity among the studies (I2 = 2.3%; P = 0.402).
For ICU mortality, there was not enough evidence to
conclude that vitamin D deficiency was not associated
with increased incidence of ICU mortality in critically ill
adult patients (OR 1.43; 95% CI, 0.76, 2.70; P = 0.271).
The data for length of ICU stay for every individual
study are presented in Table 2.
Subgroup and sensitivity analyses
Table 3 shows the results of subgroup and sensitivity
analyses. Definition of vitamin D deficiency varies be-
tween studies, which may impact the overall estimates.
We therefore stratified mortality rates across different
studies based on vitamin D thresholds as a continuum,
and the finding of increased incidence of hospital mor-
tality in critically ill adult patients was consistently
found in each stratum. Our sensitivity analyses sug-
gested that the overall estimates were not materially
altered by changing pooling models (fixed-effects model:
OR 1.76; 95% CI, 1.38, 2.24 and random-effects model:
OR 1.76; 95% CI, 1.37, 2.26), and also did not materi-
ally alter when any single study was removed in turn, with
a range from 1.67 (95% CI, 1.30, 2.15) to 1.82 (95% CI,
1.42, 2.34).Publication bias
Publication bias was assessed, but the low power with only
seven studies limited the interpretability of the finding.
Discussion
Main findings
To the best of our knowledge, this is the first meta-
analysis to explore the effect of vitamin D deficiency on
mortality in critically ill adult patients. This study
suggests that vitamin D deficiency is associated with in-
creased hospital mortality in critically ill adult patients.
The effect of vitamin D deficiency was observed in every
stratum of our subgroup analyses. In addition, a relatively
small number of samples (only two studies [19,22]) pro-
vided data on ICU mortality, and the final estimate showed
there was not enough evidence to conclude that vitamin D
deficiency was not associated with increased incidence
of ICU mortality in critically ill adult patients (OR 1.43;
95% CI, 0.76, 2.70; P = 0.271).
Possible mechanism
Although vitamin D deficiency may increase the inci-
dence of hospital mortality in the critically ill adult pa-
tients, the reason remains unclear and can be explained
by several different mechanisms. First, a range of biological




Amrein et al./2014 [22] Aygencel et al./2013 [19] Hu et al./2013 [18] Nair et al./2012 [21] Higgins et al./2012 [20] Venkatram et al./2011 [8] Braun et al./2011 [17]
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Patients, n 655 201 216 100 196 437 2,399
Case patients,
n (%)
394 (60.2%) 139 (69.2%) 95 (44.0%) 24 (24.0%) 50 (25.5%) 340 (77.8%) 637 (26.6%)
Male patients,
n (%)
412 (62.9%) 113 (56.0%) 120 (55.6%) 65 (65.0%) 121 (62.0%) 208 (47.5%) 1,030 (43.0%)
Age, y, mean 65 (22)a 66 (21)a 64 (25)a 52 ± 17b 64 ± 14b 56.6 ± 17.1b 64.9 ± 16.6b
Severity of
illness
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Figure 2 Forest plot showing the effect of vitamin D deficiency on hospital mortality. OR, odds ratio.
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cesses in cellular growth, proliferation, and apoptosis
may be influenced by vitamin D [1,23]. Vitamin D regu-
lates the expression of the antimicrobial peptides cathelici-
din (LL-37) and β-defensin, both of which have functional
effectors within the immune system [24,25]. Cathelicidin
can fight against a broad spectrum of infectious agents,
including Gram-negative and -positive bacteria, as well as
fungi [24]. Second, as vitamin D is a known link between
toll-like receptors (TLR) activation and innate immunity
[26], and vitamin D receptors are expressed in T cells [27],
activated B cells [28], and dendritic cells [29], vitamin D
deficiency may increase the risk of inflammation and sepsis
in the critically ill by the suppression of immune reactiv-
ity and stimulatory effects on innate immunity [30-32].
Third, vitamin D has also been found to downregulate
proinflammatory cytokines such as interferon-γ, tumor
necrosis factor-α, and IL-1, IL-2, IL-6, IL-8, IL-12, as well
as T helper 1 cells and B cells in the adaptive immune
system [33,34]. At the same time, vitamin D upregulatesFigure 3 Forest plot showing the effect of vitamin D deficiency on ICanti-inflammatory cytokines, such as IL-4, IL-5 and IL-10.
It promotes the expression of T-regulatory cells, which
turn off the adaptive immune response [35]. These studies
suggest that vitamin D deficiency disturb the innate im-
munity system and compromises the ability of critically
ill patients to downregulate the adaptive immune re-
sponse. In addition, the tissue requires more vitamin D
in critically ill patients, and vitamin D deficiency may
result in widespread tissue dysfunction [36]. These effects
may explain why increasing mortality results from systemic
inflammatory response syndrome, organ failure and meta-
bolic dysfunction in critically ill patients.
Clinical implications
Our findings may have several implications. As vitamin D
deficiency impacts on mortality in critically ill pa-
tients, vitamin D levels may be used to predict the out-
comes in critically ill patients. Unlike markers such as
C-reactive protein (CRP), procalcitonin, D-dimer and
leucocyte counts, which have been shown to predictU mortality. OR, odds ratio.
Table 2 ICU length of stay among studies
Study Year Vitamin D classification ICU length of
stay (days)
Amrein et al. [22] 2014 Deficiency, <20 ng/ml 6.9 (9.8)a
insufficiency, 20 to 30 ng/ml 4.9 (7.7)a
sufficiency, >30 ng/ml 5.2 (6.5)a
Aygencel et al. [19] 2013 Insufficiency, <20 ng/ml 9 (5, 14)b
sufficiency, ≥20 ng/ml 8 (5, 13)b
Hu et al. [18] 2013 Deficiency, <20 ng/ml 10.5 (6.8, 25.3)b
insufficiency, 20 to 30 ng/ml 8.6 (6.9, 20.5)b
sufficiency, >30 ng/ml 15.2 (10.3, 23.6)b
Nair et al. [21] 2012 Deficiency, <10 ng/ml 12 (2, 14)b
insufficiency,10 to 20 ng/ml 7 (4, 15)b
sufficiency, >20 ng/ml 4 (3, 10)b
Higgins et al. [20] 2012 Deficient, ≤12 ng/ml 10.6 ± 8.4c
insufficient, 12 to 24 ng/ml 6.8 ± 6.0c
sufficient, >24 ng/ml 5.9 ± 5.4c
Venkatram et al. [8] 2011 Deficiency, <20 ng/ml 4.3 ± 4.5c
insufficiency, 20 to 30 ng/ml 3.7 ± 3.9c
sufficiency, >30 ng/ml 4.2 ± 3.7c
Braun et al. [17] 2011 - -
aMedian (interquartile range); bmedian (Q1, Q3); cmean ± SD.
Table 3 Subgroup and sensitivity analyses for hospital
mortality





Total [8,17-22] 7 1.76 (1.38, 2.24) 0.402 2.3%
25(OH)D level as a
cutoff for vitamin D
deficiency
20 ng/ml [8,18,22] 3 2.12 (1.35, 3.34) 0.198 38.3%
15 ng/ml [17] 1 1.72 (1.27, 2.33) - -
12 ng/ml [20] 1 1.12 (0.45, 2.70) - -
10 ng/ml [21] 1 1.13 (0.18, 7.27) - -
Sensitivity analysis
Multicenter [17,20,21] 3 1.63 (1.23, 2.17) 0.623 0.0%
Prospective cohort
[18,20,21]
3 1.83 (1.03, 3.24) 0.241 29.7%
One-study-out method
Amrein [22] 1 1.79 (1.23, 2.70) 0.284 20.5%
Hu [18] 1 1.67 (1.30, 2.15) 0.511 0.0%
Nair [21] 1 1.77 (1.39, 2.26) 0.298 18.3%
Higgins [20] 1 1.82 (1.42, 2.34) 0.396 1.8%
Venkatram [8] 1 1.72 (1.35, 2.19) 0.571 0.0%




Fixed-effects model 6 1.76 (1.38, 2.24) 0.402 2.3%
Random-effects model 6 1.76 (1.37, 2.26) 0.402 2.3%
25(OH)D, 25-hydroxyvitamin D.
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levels may not only predict disease severity and outcomes
but also contribute to the comorbidities commonly seen
in critically illness. Our meta-analysis may offer possibil-
ities for therapeutic exploitation of vitamin D supplemen-
tation in critical illness. A recent randomized clinical trial
by Amrein and colleagues [38] suggested that administra-
tion of high-dose vitamin D3 compared with placebo did
not improve hospital length of stay and hospital mortality
for vitamin D-deficient (≤20 ng/mL) patients who are
critically ill. However, lower hospital mortality was ob-
served in a subgroup of patients with severe vitamin D
deficiency (≤12 ng/mL) [38]. These findings should be
interpreted with caution and researchers should probe
further into the effect of vitamin D supplementation on
adverse outcomes, as well as the assessment of its dosing
efficacy and safety.
Strengths and limitations
The generalizability of our meta-analysis has been
enhanced by its exhaustive search without language
restrictions and by using the MOOSE guidelines as
our systematic review methods. Also, we are able to en-
hance the precision of the risk estimates with our strict
inclusive criteria. We included seven cohort studies with
high quality, which minimized the likelihood of recall
interviewer and selection biases that can be a con-
cern in epidemiological studies. We did not find anysignificant heterogeneity between the studies included in
our meta-analysis.
Several limitations should be acknowledged. First,
some studies in this analysis did not utilize liquid
chromatography-tandem mass spectrometry (LC-MS/MS)
to determine 25(OH) D levels [39], which may potentially
impact on the overall results. Second, vitamin D levels
have seasonal variations, which have the highest mean
values in August and the lowest mean levels in March
[22]. Only the study by Amrein and colleagues [22] took
seasonal influence into account, so we could not adjust
this factor. Third, most studies were conducted in some
specific ICUs, such as surgical ICU or medical ICU, which
may not represent all ICU patients. Fourth, the definition
of vitamin D deficiency in critically ill patients remains
inconsistent, and in our meta-analysis, different criteria of
vitamin D definition was used among the studies.
Conclusions
This study showed that vitamin D deficiency is associ-
ated with increased hospital mortality in critically ill
Zhang et al. Critical Care 2014, 18:684 Page 7 of 8
http://ccforum.com/content/18/6/684adult patients. However, there is not enough evidence to
conclude that vitamin D deficiency is not associated with
increased ICU mortality in critically ill adult patients,
which requires more studies to probe this issue further
in the future.
Key messages
 Vitamin D deficiency is associated with increased
incidence of hospital mortality in critically ill adult
patients
 Current evidence about vitamin D deficiency and
increased ICU mortality is still not sufficient to draw
a firm conclusion
 More studies should probe further into the effect on
ICU mortality in critically ill adult patients
Additional file
Additional file 1: Methodological quality assessment (risk of bias)
of included studies by Newcastle-Ottawa scales.
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